References

Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity [editorial]

10.1093/jnci/djj065 · 2006 · External reference

Oxygen toxicity: a radical explanation

10.1242/jeb.201.8.1203 · 1998 · External reference

Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts

10.1073/pnas.93.21.11853 · 1996 · External reference

Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase

10.1124/jpet.110.176321 · 2010 · External reference

Superoxide dismutase in redox biology: the roles of super-oxide and hydrogen peroxide

10.2174/187152011795677544 · 2011 · External reference

Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress

10.18632/aging.100291 · 2011 · External reference

Targeting the TGF-β1 pathway to prevent normal tissue injury after cancer therapy

10.1634/theoncologist.2009-s101 · 2010 · External reference

What can ecology teach us about cancer?

10.1593/tlo.11154 · 2011 · External reference

Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy

1995 · External reference

A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells

10.1016/j.freeradbiomed.2008.10.030 · 2009 · External reference

Anticancer therapy by overexpression of superoxide dismutase

10.1089/15230860152409095 · 2001 · External reference

Controlling tumor growth by modulating endogenous production of reactive oxygen species

10.1158/0008-5472.948.65.3 · 2005 · External reference

The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity [letter to the editor]

10.1158/0008-5472.can-05-2053 · 2006 · External reference

Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir

10.1093/jnci/djj049 · 2006 · External reference

Effects of MnDPDP and ICRF-18[7] on doxorubicin-induced cardiotoxicity and anticancer activity

10.1593/tlo.11304 · 2012 · External reference

Mangafodipir as a cytoprotective adjunct to chemotherapy—a case report

10.1080/02841860802680427 · 2009 · External reference

10.1593/tlo.11277 · 2012 · Admitted local publication

Mangafodipir prevents liver injury induced by acetaminophen in the mouse

10.1016/s0168-8278(03)00325-8 · 2003 · External reference

Antioxidant activity of mangafodipir is not a new finding [letter to the editor]

10.1016/j.jhep.2004.02.022 · 2004 · External reference

Influence of chronic MnCl2 and EDTA treatment on tissue levels and urinary excretion of trace metals in rats

10.1007/bf01056081 · 1982 · External reference

Metabolism and pharmacokinetics of MnDPDP in man

10.1080/02841859709172400 · 1997 · External reference

NMR relaxation studies with MnDPDP

10.1080/02841859709172403 · 1997 · External reference

Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to imaging of the heart

10.1002/nbm.943 · 2004 · External reference

Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?

10.1006/bbrc.1998.0131 · 1999 · External reference

Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium

10.1080/028418501127347340 · 2001 · External reference

Manganese(II) N,N′-dipyridoxylethylenediamine-N,N′-diacetate 5,5-bis (phosphate)

1989 · External reference

Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR

10.1007/s007750100290 · 2002 · External reference

Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2

10.1080/02841859709172402 · 1997 · External reference

Guidelines for the welfare and use of animals in cancer research

10.1038/sj.bjc.6605642 · 2010 · External reference

Manganese toxicity upon overexposure

10.1002/nbm.931 · 2004 · External reference

Zinc homeostasis in humans

10.1093/jn/130.5.1360s · 2000 · External reference

Zinc content of normal human serum and its correlation with some hematic parameters

10.1007/bf00205198 · 1994 · External reference

Activation of super-oxide dismutases: putting the metal to the pedal

10.1016/j.bbamcr.2006.05.003 · 2006 · External reference

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid

1980 · External reference

Radioprotectors and mitigators of radiation-induced normal tissue injury

10.1634/theoncologist.2009-s104 · 2010 · External reference

Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury

10.1016/s0360-3016(03)01369-5 · 2003 · External reference

Role of superoxide dismutase in cancer: a review

2003 · External reference

The role of manganese superoxide dismutase in inflammation defense

2011 · External reference

Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells

10.1158/1541-7786.mcr-08-0253 · 2008 · External reference

Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-[7] cancer cell phenotype

1999 · External reference

Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts

10.1126/science.275.5306.1649 · 1997 · External reference

Prooxidant states and tumor promotion

10.1126/science.2981433 · 1985 · External reference

Production of large amounts of hydrogen peroxide by human tumor cells

1991 · External reference

Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p3[8] mitogen-activated protein kinase activation and sensitization to genotoxic stress

10.1128/mcb.21.20.6913-6926.2001 · 2001 · External reference

The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma

2003 · External reference

Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells

10.1128/mcb.25.17.7758-7769.2005 · 2005 · External reference

Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells

10.1073/pnas.90.7.3113 · 1993 · External reference

Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase

10.1038/sj.onc.1200852 · 1997 · External reference

Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-2[5] cells

10.1089/hum.1997.8.5-585 · 1997 · External reference

Overexpression of manganese superoxide dismutase in DU14[5] human prostate carcinoma cells has multiple effects on cell phenotype

10.1002/(sici)1097-0045(19980515)35:3<221::aid-pros8>3.0.co;2-j · 1998 · External reference

Immune parameters affecting the efficacy of chemotherapeutic regimens

10.1038/nrclinonc.2010.223 · 2011 · External reference

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

10.1038/bjc.2011.100 · 2011 · External reference

Inhibition of tumour promotion by a biomimetic SOD

10.1126/science.6857269 · 1983 · External reference

Mangafodipir (MnDPDP) and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries

10.1016/s0022-3565(25)23807-1 · 1994 · External reference

Manganese superoxide dismutase, MnSOD and its mimics

10.1016/j.bbadis.2011.12.002 · 2012 · External reference